Patents by Inventor Ryo Yoshimoto

Ryo Yoshimoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10549787
    Abstract: An object of the present invention is to provide a vehicle body floor structure capable of effectively preventing deformation of a floor panel by increasing bending strength of the floor panel even when an upper reinforcing member of the floor panel is removed. A vehicle body floor structure of the present invention includes a dash cross member disposed along a kick-up portion on a lower surface side of a floor panel, a novel front side frame having an outer frame and an inner frame at a rear portion of a side frame body, and a floor panel on which beads are formed to form a closed cross-section in cooperation with the outer frame and the inner frame.
    Type: Grant
    Filed: April 18, 2018
    Date of Patent: February 4, 2020
    Assignee: HONDA MOTOR CO., LTD.
    Inventors: Ryo Kita, Takuya Morisawa, Takeshi Yoshimoto, Hirotaka Yamaguchi, Tomonari Takahashi
  • Publication number: 20200036074
    Abstract: The invention provides a dielectric waveguide for transmitting millimeter waves or sub-millimeter waves. The dielectric waveguide is easily processed and connected even when having a small diameter, and can provide a connection structure exhibiting low transmission and return losses of high frequency signals. The dielectric waveguide includes a dielectric waveguide body and a dielectric waveguide end having a lower permittivity than the dielectric waveguide body. The dielectric waveguide body and the dielectric waveguide end are seamlessly and monolithically formed from the same material.
    Type: Application
    Filed: September 29, 2017
    Publication date: January 30, 2020
    Applicants: DAIKIN INDUSTRIES, LTD., NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
    Inventors: Hiroyuki YOSHIMOTO, Dai FUKAMI, Taku YAMANAKA, Masahiro HORIBE, Yuto KATO, Ryo SAKAMAKI
  • Publication number: 20190225942
    Abstract: A scaffold material for cell culturing using a nucleic acid aptamer that can be chemically synthesized, containing no animal-derived components, and having high biocompatibility is provided. A cell scaffold material containing an E-cadherin binding nucleic acid aptamer.
    Type: Application
    Filed: August 22, 2017
    Publication date: July 25, 2019
    Applicants: NISSAN CHEMICAL CORPORATION, THE UNIVERSITY OF TOKYO
    Inventors: Hitoshi FURUSHO, Keitaro YOSHIMOTO, Ryo MARUYAMA
  • Publication number: 20180105655
    Abstract: Provided is a process for producing aqueous-liquid absorbing resin particles which, even after transportation or a diaper production step, are capable of combining the property of enabling liquid passing through interstices among the swollen gel particles with absorption performance under load. The present invention is: a process for producing aqueous-liquid absorbing resin articles (P), characterized by subjecting resin particles (B) that comprise a crosslinked polymer (A) comprising essential constituent units derived from a water-soluble vinyl monomer (a1) and/or a vinyl monomer (a2) which become a water-soluble vinyl monomer (al) upon hydrolysis and from a crosslinking agent (b), to surface treatment by a specific method using a C4 or lower polyhydric alcohol (c), a polyvalent metal salt (d), and a polyglycidyl compound (e); and the aqueous-liquid absorbing resin articles (P).
    Type: Application
    Filed: March 7, 2016
    Publication date: April 19, 2018
    Inventors: Yusuke Matsubara, Ryo Yoshimoto, Sho Akahane
  • Publication number: 20160060669
    Abstract: A glucose production method produces glucose by using excrement from living matter that is disposed as waste, without consuming food resources or agricultural resources, which can stably provide glucose at low cost without being affected by crop yields.
    Type: Application
    Filed: May 8, 2014
    Publication date: March 3, 2016
    Inventors: Kenichi ABURAI, Yukiko KIKUCHI, Ryo YOSHIMOTO, Yoshihiro KANAI, Yasutaka SEKI
  • Patent number: 8044070
    Abstract: Provided are compounds of a formula (I) and their pharmaceutically-acceptable salts: wherein X1, X2 and X3 each independently represent N or CH; W represents the following formula (II): or the following formula (III): Y represents a group of a formula (IV): The compounds have a histamine-H3 receptor antagonistic or inverse-agonistic activity and are useful for remedy and/or prevention of obesity, diabetes, hormone secretion disorders, sleep disorders, etc.
    Type: Grant
    Filed: August 13, 2009
    Date of Patent: October 25, 2011
    Assignee: MSD K.K.
    Inventors: Norikazu Ohtake, Akira Naya, Yuji Haga, Makoto Jitsuoka, Takuya Suga, Ryo Yoshimoto, Shigeru Tokita, Akio Kanatani
  • Patent number: 7834182
    Abstract: Provided are a histamine-H3 receptor antagonist; and a preventive and/or a remedy for metabolic system diseases such as obesity, diabetes, hormone secretion disorder, hyperlipemia, gout, fatty liver, circulatory system diseases, for example, stenocardia, acute/congestive cardiac insufficiency, cardiac infarction, coronary arteriosclerosis, hypertension, nephropathy, sleep disorder and various diseases accompanied by sleep disorder such as idiopathic hypersomnia, repetitive hypersomnia, true hypersomnia, narcolepsy, sleep periodic acromotion disorder, sleep apnea syndrome, circadian rhythm disorder, chronic fatigue syndrome, REM sleep disorder, senile insomnia, night worker sleep insanitation, idiopathic insomnia, repetitive insomnia, true insomnia, electrolyte metabolism disorder; and central and peripheral nervous system diseases such as bulimia, emotional disorder, melancholia, anxiety, epilepsy, delirium, dementia, shinzophrenia, attention deficit/hyperactivity disorder, memory disorder, Alzheimer's diseas
    Type: Grant
    Filed: March 6, 2009
    Date of Patent: November 16, 2010
    Assignee: Banyu Pharmaceutical Co., Ltd.
    Inventors: Norikazu Ohtake, Ryo Yoshimoto, Shigeru Tokita, Akio Kanatani, Sayaka Mizutani
  • Publication number: 20100210637
    Abstract: Provided are compounds of a formula (I) and their pharmaceutically-acceptable salts: wherein X1, X2 and X3 each independently represent N or CH; W represents the following formula (II): or the following formula (III): Y represents a group of a formula (IV): The compounds have a histamine-H3 receptor antagonistic or inverse-agonistic activity and are useful for remedy and/or prevention of obesity, diabetes, hormone secretion disorders, sleep disorders, etc.
    Type: Application
    Filed: August 13, 2009
    Publication date: August 19, 2010
    Inventors: Norikazu Ohtake, Akira Naya, Yuji Haga, Makoto Jitsuoka, Takuya Suga, Ryo Yoshimoto, Shigeru Tokita, Akio Kanatani
  • Publication number: 20100137391
    Abstract: Disclosed are: novel use of an agonist histamine receptor H3 (e.g., Imetit) for prevention of obesity or the reduction of food intake; a method for evaluation of a compound for use as a therapeutic agent targeted to histamine receptor HR protein; and a compound provided by the method.
    Type: Application
    Filed: September 13, 2006
    Publication date: June 3, 2010
    Inventors: Ryo Yoshimoto, Akane Ishihara, Akio Kanatani, Shigeru Tokita
  • Patent number: 7645756
    Abstract: The invention provides a compound or its pharmaceutically-acceptable salt of formula wherein A1 is a hydrogen, etc.; j and k are 0 or 1; is a double bond, etc.; is a double bond, etc.; one of W1 and W2 is E—O—W, etc., and the other is a hydrogen atom, etc.; E is a divalent group derived from a benzene ring, etc., by removing two hydrogen atoms therefrom; W is a group of formula (II-1): which has a histamine-H3 receptor antagonistic effect or a histamine-H3 receptor inverse-agonistic effect and is useful for prevention or remedy of metabolic system diseases, circulatory system diseases or nervous system diseases.
    Type: Grant
    Filed: February 17, 2005
    Date of Patent: January 12, 2010
    Assignee: Banyu Pharmaceutical Co. Ltd.
    Inventors: Toshiyuki Takahashi, Akio Kanatani, Shigeru Tokita, Ryo Yoshimoto
  • Patent number: 7595316
    Abstract: Compound of the formula: (I) [wherein each of X1, X2 and X3 independently represents N or CH, W represents the formula (II):(II) or the formula (III):(III) and Y represents a group of the formula (IV):(IV)], or a pharmacologically acceptable salt thereof. This compound exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful of the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep, disorder, etc.
    Type: Grant
    Filed: June 24, 2004
    Date of Patent: September 29, 2009
    Assignee: Banyu Pharmaceutical Co., Ltd.
    Inventors: Norikazu Ohtake, Akira Naya, Yuji Haga, Makoto Jitsuoka, Takuya Suga, Ryo Yoshimoto, Shigeru Tokita, Akio Kanatani
  • Publication number: 20090203710
    Abstract: Provided are a histamine-H3 receptor antagonist; and a preventive and/or a remedy for metabolic system diseases such as obesity, diabetes, hormone secretion disorder, hyperlipemia, gout, fatty liver, circulatory system diseases, for example, stenocardia, acute/congestive cardiac insufficiency, cardiac infarction, coronary arteriosclerosis, hypertension, nephropathy, sleep disorder and various diseases accompanied by sleep disorder such as idiopathic hypersomnia repetitive hypersomnia, true hypersomnia, narcolepsy, sleep periodic acromotion disorder, sleep apnea syndrome, circadian rhythm disorder, chronic fatigue syndrome, REM sleep disorder, senile insomnia, night worker sleep insanitation, idiopathic insomnia, repetitive insomnia, true insomnia, electrolyte metabolism disorder; and central and peripheral nervous system diseases such as bulimia, emotional disorder, melancholia, anxiety, epilepsy, delirium, dementia, shinzophrenia, attention deficit/hyperactivity disorder, memory disorder, Alzheimer's disease
    Type: Application
    Filed: March 6, 2009
    Publication date: August 13, 2009
    Inventors: Norikazu Ohtake, Ryo Yoshimoto, Shigeru Tokita, Akio Kanatani, Sayaka Mizutani
  • Patent number: 7547693
    Abstract: Provided are a histamine-H3 receptor antagonist; and a preventive and/or a remedy for metabolic system diseases such as obesity, diabetes, hormone secretion disorder, hyperlipemia, gout, fatty liver, circulatory system diseases, for example, stenocardia, acute/congestive cardiac insufficiency, cardiac infarction, coronary arteriosclerosis, hypertension, nephropathy, sleep disorder and various diseases accompanied by sleep disorder such as idiopathic hypersomnnia, repetitive hypersomnnia, true hypersomnnia, narcolepsy, sleep periodic acromotion disorder, sleep apnea syndrome, circadian rhythm disorder, chronic fatigue syndrome, REM sleep disorder, senile insomnia, night worker sleep insanitation, idiopathic insomnia, repetitive insomnia, true insomnia, electrolyte metabolism disorder, and central and peripheral nervous system diseases such as bulimia, emotional disorder, melancholia, anxiety, epilepsy, delirium, dementia, shinzophrenia, attention deficit/hyperactivity disorder, memory disorder, Alzheimer's dis
    Type: Grant
    Filed: September 21, 2004
    Date of Patent: June 16, 2009
    Assignee: Banyu Pharmaceutical Co. Ltd.
    Inventors: Norikazu Ohtake, Ryo Yoshimoto, Shigeru Tokita, Akio Kanatani, Sayaka Mizutani
  • Publication number: 20070167453
    Abstract: The invention provides a compound or its pharmaceutically-acceptable salt of formula wherein A1 is a hydrogen, etc.; j and k are 0 or 1; is a double bond, etc.; is a double bond, etc.; one of W1 and W2 is E-O—W, etc., and the other is a hydrogen atom, etc.; E is a divalent group derived from a benzene ring, etc., by removing two hydrogen atoms therefrom; W is a group of formula (II-1): which has a histamine-H3 receptor antagonistic effect or a histamine-H3 receptor inverse-agonistic effect and is useful for prevention or remedy of metabolic system diseases, circulatory system diseases or nervous system diseases.
    Type: Application
    Filed: February 17, 2005
    Publication date: July 19, 2007
    Inventors: Toshiyuki Takahashi, Akio Kunatani, Shigeru Tokita, Ryo Yoshimoto
  • Publication number: 20070105901
    Abstract: Provided are a histamine-H3 receptor antagonist; and a preventive and/or a remedy for metabolic system diseases such as obesity, diabetes, hormone secretion disorder, hyperlipemia, gout, fatty liver, circulatory system diseases, for example, stenocardia, acute/congestive cardiac insufficiency, cardiac infarction, coronary arteriosclerosis, hypertension, nephropathy, sleep disorder and various diseases accompanied by sleep disorder such as idiopathic hypersomnia, repetitive hypersomnia, true hypersomnia, narcolepsy, sleep periodic acromotion disorder, sleep apnea syndrome, circadian rhythm disorder, chronic fatigue syndrome, REM sleep disorder, senile insomnia, night worker sleep insanitation, idiopathic insomnia, repetitive insomnia, true insomnia, electrolyte metabolism disorder, and central and peripheral nervous system diseases such as bulimia, emotional disorder, melancholia, anxiety, epilepsy, delirium, dementia, shinzophrenia, attention deficit/hyperactivity disorder, memory disorder, Alzheimer's diseas
    Type: Application
    Filed: September 21, 2004
    Publication date: May 10, 2007
    Inventors: Norikazu Ohtake, Ryo Yoshimoto, Shigeru Tokita, Akio Kanatani, Sayaka Date
  • Publication number: 20060178375
    Abstract: Compound of the formula: (I) [wherein each of X1, X2, and X3 independently represents N or CH, W represents the formula (II):(II) or the formula (III):(III) and Y represents a group of the formula (IV):(IV)], or a pharmacologically acceptable salt thereof. This compound exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful of the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep, disorder, etc.
    Type: Application
    Filed: June 24, 2004
    Publication date: August 10, 2006
    Inventors: Norikazu Ohtake, Akira Naya, Yuji Haga, Makoto Jitsuoka, Takuya Suga, Ryo Yoshimoto, Shigeru Tokita, Akio Kanatani